77 related articles for article (PubMed ID: 2465821)
1. Keratin expression in mouse epidermal tumors.
Roop DR; Mehrel T; Krieg TM; Nakazawa H; Cheng CK; Yuspa SH
Carcinog Compr Surv; 1989; 11():257-71. PubMed ID: 2465821
[No Abstract] [Full Text] [Related]
2. VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development.
Larcher F; Murillas R; Bolontrade M; Conti CJ; Jorcano JL
Oncogene; 1998 Jul; 17(3):303-11. PubMed ID: 9690512
[TBL] [Abstract][Full Text] [Related]
3. Difluoromethylornithine chemoprevention of epidermal carcinogenesis in K14-HPV16 transgenic mice.
Arbeit JM; Riley RR; Huey B; Porter C; Kelloff G; Lubet R; Ward JM; Pinkel D
Cancer Res; 1999 Aug; 59(15):3610-20. PubMed ID: 10446971
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
La E; Muga SJ; Locniskar MF; Fischer SM
Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
[TBL] [Abstract][Full Text] [Related]
5. Genetic susceptibility to tumor progression in mouse skin carcinogenesis.
Stern MC; Conti CJ
Prog Clin Biol Res; 1996; 395():47-55. PubMed ID: 8895983
[No Abstract] [Full Text] [Related]
6. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
[TBL] [Abstract][Full Text] [Related]
7. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J
Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic evidence for gene amplification in mouse skin carcinogenesis.
Aldaz CM; Conti CJ; O'Connell J; Yuspa SH; Klein-Szanto AJ; Slaga TJ
Cancer Res; 1986 Jul; 46(7):3565-8. PubMed ID: 3708588
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis.
Tiano HF; Loftin CD; Akunda J; Lee CA; Spalding J; Sessoms A; Dunson DB; Rogan EG; Morham SG; Smart RC; Langenbach R
Cancer Res; 2002 Jun; 62(12):3395-401. PubMed ID: 12067981
[TBL] [Abstract][Full Text] [Related]
10. TGF alpha and v-fos cooperation in transgenic mouse epidermis induces aberrant keratinocyte differentiation and stable, autonomous papillomas.
Wang XJ; Greenhalgh DA; Lu XR; Bickenbach JR; Roop DR
Oncogene; 1995 Jan; 10(2):279-89. PubMed ID: 7530825
[TBL] [Abstract][Full Text] [Related]
11. Keratin modifications in epidermis, papillomas, and carcinomas during two-stage carcinogenesis in the SENCAR mouse.
Nelson KG; Slaga TJ
Cancer Res; 1982 Oct; 42(10):4176-81. PubMed ID: 6179598
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemical study of the distribution of carcinoembryonic antigen and keratin in tumors of epidermal origin. I: Squamous and basal cell epitheliomas].
Betlloch Mas I; Castells Rodellas A
Med Cutan Ibero Lat Am; 1989; 17(2):121-6. PubMed ID: 2474116
[TBL] [Abstract][Full Text] [Related]
13. Cooperation between v-fos and v-rasHA induces autonomous papillomas in transgenic epidermis but not malignant conversion.
Greenhalgh DA; Quintanilla MI; Orengo CC; Barber JL; Eckhardt JN; Rothnagel JA; Roop DR
Cancer Res; 1993 Nov; 53(21):5071-5. PubMed ID: 7693330
[TBL] [Abstract][Full Text] [Related]
14. Ornithine decarboxylase expression in cutaneous papillomas in SENCAR mice is associated with altered expression of keratins 1 and 10.
Sundberg JP; Erickson AA; Roop DR; Binder RL
Cancer Res; 1994 Mar; 54(5):1344-51. PubMed ID: 7509717
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
[TBL] [Abstract][Full Text] [Related]
16. Genetic deletion of p21WAF1 enhances papilloma formation but not malignant conversion in experimental mouse skin carcinogenesis.
Weinberg WC; Fernandez-Salas E; Morgan DL; Shalizi A; Mirosh E; Stanulis E; Deng C; Hennings H; Yuspa SH
Cancer Res; 1999 May; 59(9):2050-4. PubMed ID: 10232585
[TBL] [Abstract][Full Text] [Related]
17. An antitumorigenic role for murine 8S-lipoxygenase in skin carcinogenesis.
Kim E; Rundhaug JE; Benavides F; Yang P; Newman RA; Fischer SM
Oncogene; 2005 Feb; 24(7):1174-87. PubMed ID: 15558016
[TBL] [Abstract][Full Text] [Related]
18. Identification of differentially expressed genes in chemically induced skin tumors.
Rutberg SE; Lee EJ; Hansen LH; Glick AB; Yuspa SH
Mol Carcinog; 1997 Sep; 20(1):88-98. PubMed ID: 9328439
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic and cytogenetic characteristics of different stages during spontaneous transformation of mouse keratinocytes in vitro.
Fusenig NE; Dzarlieva-Petrusevska RT; Breitkreutz D
Carcinog Compr Surv; 1985; 9():293-326. PubMed ID: 2414007
[No Abstract] [Full Text] [Related]
20. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mice expressing epidermal-targeted v-fos induces rasHA-activated papillomas and carcinomas without p53 mutation: association of v-fos expression with promotion and tumor autonomy.
Greenhalgh DA; Wang XJ; Eckhardt JN; Roop DR
Cell Growth Differ; 1995 May; 6(5):579-86. PubMed ID: 7544154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
